APA (7th ed.) Citation

Susu Xiao, Yu Wang, Wenqiong Ma, Ping Zhou, Biqiong Wang, Zhouxue Wu, . . . Shaozhi Fu. (2022). Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Susu Xiao, et al. Intraperitoneal Administration of Thermosensitive Hydrogel Co-loaded with Norcantharidin Nanoparticles and Oxaliplatin Inhibits Malignant Ascites of Hepatocellular Carcinoma. Taylor & Francis Group, 2022.

MLA (9th ed.) Citation

Susu Xiao, et al. Intraperitoneal Administration of Thermosensitive Hydrogel Co-loaded with Norcantharidin Nanoparticles and Oxaliplatin Inhibits Malignant Ascites of Hepatocellular Carcinoma. Taylor & Francis Group, 2022.